ATLASATLAS fair value
CHF 12.19
Above fair value · 43% premium
Range: CHF 11–CHF 13Fair valuePrice
CURATIS N (CURN.SW)
CURATIS N stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · SIX Swiss Exchange · Switzerland
CHF 17.45▲ 0.00%
Prices as of Oct 26, 2026 · CHF
Chance of rising in 1 month
45%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on CURATIS N in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On CURATIS N
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates CURATIS N's fair value at about CHF 12.19 per share (reasonable range: CHF 10.97 to CHF 13.40). At CHF 17.45, the stock trades 43% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives CURATIS N a 45% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 14.60 and CHF 19.78; in 9 out of 10, between CHF 11.16 and CHF 25.89. Estimated annual volatility is 68%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CHF 97.6M
- Market cap (USD)
- $118M
- 52-week high
- CHF 27.90
- 52-week low
- CHF 11.05
- Revenue (12 months)
- CHF 13.5M
- Gross margin
- 24.1%
- Operating margin
- -5.1%
- Net margin
- -4.9%
- Beta
- -0.71
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. CURATIS N sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks CURN.SW has traded between CHF 11.05 and CHF 27.90. Today it is 37.5% below that high and 58% above its low.
Its beta is -0.71: it tends to move less than the market.
About the company
Curatis Holding AG engages in the acquisition, development, and commercialization of medicines for the prevention, diagnosis, and treatment of rare and specialty care diseases.
Want to see everything about CURATIS N?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is CURATIS N (CURN.SW) fair value?
About CHF 12.19 per share according to ATLAS (reasonable range: CHF 10.97 to CHF 13.40). With the stock at CHF 17.45, it is 43% above it.
What is the chance CURN.SW goes up next month?
45%: close to a coin flip. In half of the simulated outcomes, CURN.SW ends the month between CHF 14.60 and CHF 19.78.
How big is CURATIS N and what is its P/E ratio?
CURATIS N's market capitalization is CHF 97.6M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is CURN.SW?
ATLAS estimates annual volatility at 68%. In a typical month, half of the outcomes end between CHF 14.60 and CHF 19.78.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer